rs646534
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_145716.4(SSBP3):c.367-10916C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.411 in 151,926 control chromosomes in the GnomAD database, including 13,019 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.41 ( 13019 hom., cov: 32)
Consequence
SSBP3
NM_145716.4 intron
NM_145716.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.426
Publications
3 publications found
Genes affected
SSBP3 (HGNC:15674): (single stranded DNA binding protein 3) Predicted to enable single-stranded DNA binding activity and transcription coactivator activity. Predicted to be involved in head development and positive regulation of transcription by RNA polymerase II. Predicted to act upstream of or within hematopoietic progenitor cell differentiation. Predicted to be part of protein-containing complex. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.465 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SSBP3 | NM_145716.4 | c.367-10916C>T | intron_variant | Intron 5 of 17 | ENST00000610401.6 | NP_663768.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SSBP3 | ENST00000610401.6 | c.367-10916C>T | intron_variant | Intron 5 of 17 | 5 | NM_145716.4 | ENSP00000479674.2 |
Frequencies
GnomAD3 genomes AF: 0.411 AC: 62431AN: 151808Hom.: 13006 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
62431
AN:
151808
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.411 AC: 62492AN: 151926Hom.: 13019 Cov.: 32 AF XY: 0.408 AC XY: 30268AN XY: 74262 show subpopulations
GnomAD4 genome
AF:
AC:
62492
AN:
151926
Hom.:
Cov.:
32
AF XY:
AC XY:
30268
AN XY:
74262
show subpopulations
African (AFR)
AF:
AC:
16822
AN:
41384
American (AMR)
AF:
AC:
5761
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
AC:
1203
AN:
3466
East Asian (EAS)
AF:
AC:
1225
AN:
5184
South Asian (SAS)
AF:
AC:
2324
AN:
4826
European-Finnish (FIN)
AF:
AC:
3957
AN:
10562
Middle Eastern (MID)
AF:
AC:
105
AN:
292
European-Non Finnish (NFE)
AF:
AC:
29967
AN:
67932
Other (OTH)
AF:
AC:
839
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1902
3804
5707
7609
9511
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
604
1208
1812
2416
3020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1424
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.